المؤلفون: Motzer, R, Alekseev, B, Rha, SY, Porta, C, Eto, M, Powles, T, Grunwald, V, Hutson, TE, Kopyltsov, E, Mendez-Vidal, MJ, Kozlov, V, Alyasova, A, Hong, SH, Kapoor, A, Gordoa, TA, Merchan, JR, Winquist, E, Maroto, P, Goh, JC, Kim, M, Gurney, H, Patel, V, Peer, A, Procopio, G, Takagi, T, Melichar, B, Rolland, F, De Giorgi, U, Wong, S, Bedke, J, Schmidinger, M, Dutcus, CE, Smith, AD, Dutta, L, Mody, K, Perini, RF, Xing, DY, Choueiri, TK, CLEAR Trial Investigators

المصدر: NEW ENGLAND JOURNAL OF MEDICINE
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

مصطلحات موضوعية: Oncology, Male, Programmed Cell Death 1 Receptor, Medizin, Pembrolizumab, 030204 cardiovascular system & hematology, urologic and male genital diseases, chemistry.chemical_compound, 0302 clinical medicine, Renal cell carcinoma, Monoclonal, Antineoplastic Combined Chemotherapy Protocols, 80 and over, Sunitinib, Medicine, 030212 general & internal medicine, Humanized, Aged, 80 and over, General Medicine, Middle Aged, female genital diseases and pregnancy complications, Kidney Neoplasms, Progression-Free Survival, Quinolines, Female, Lenvatinib, medicine.drug, Adult, medicine.medical_specialty, Antineoplastic Agents, Antibodies, Monoclonal, Humanized, Antibodies, 03 medical and health sciences, Internal medicine, Carcinoma, Humans, Progression-free survival, Everolimus, Carcinoma, Renal Cell, Protein Kinase Inhibitors, Aged, business.industry, Phenylurea Compounds, Renal Cell, medicine.disease, Survival Analysis, chemistry, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0334f0faf7037f77f5c4cb15439bd9c2
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4803

المؤلفون: Capdevila, J, Teule, A, Lopez, C, Garcia-Carbonero, R, Benavent, M, Custodio, A, Cubillo, A, Alonso, V, Gordoa, TA, Carmona-Bayonas, A, Crespo, G, Blanco-Codesido, M, Jimenez-Fonseca, P, Viudez, A, Munoa, AL, Sevilla, I, Llanos, M, Segura, A, Hernando-Cubero, J, Manzano, JL

المصدر: Annals of Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

URL الوصول: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::efcfb68afb3f76eedecf9e774dbf8109
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4271

المؤلفون: Pernelle Lavaud, Bernadett Szabados, Rafael Morales-Barrera, Alfonso Gomez De Liano Lista, Pablo Maroto, Marine Gross Goupil, Andrea Necchi, Thomas Powles, Nick van Dijk, Alain Ravaud, Michiel S. van der Heijden, Joan Carles, Daniele Raggi, Patrizia Giannatempo, Ignacio Duran, Yohann Loriot, Teresa Alonso Gordoa, Daniel Castellano, Georgia Anguera Palacios, Félix Lefort, Guillermo de Velasco Oria de Rueda

المساهمون: Lista, Agd, van Dijk, N, de Rueda, Gdo, Necchi, A, Lavaud, P, Morales-Barrera, R, Gordoa, Ta, Maroto, P, Ravaud, A, Duran, I, Szabados, B, Castellano, D, Giannatempo, P, Loriot, Y, Carles, J, Palacios, Ga, Lefort, F, Raggi, D, Goupil, Mg, Powles, T, Van der Heijden, Ms

المصدر: EUROPEAN UROLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

مصطلحات موضوعية: Oncology, PD-L1, Male, medicine.medical_specialty, Urologic Neoplasms, Multivariate analysis, Urology, medicine.medical_treatment, 030232 urology & nephrology, 03 medical and health sciences, Immune checkpoint inhibitors, 0302 clinical medicine, Internal medicine, PD-1, medicine, Humans, Immune Checkpoint Inhibitors, Aged, Neoplasm Staging, Retrospective Studies, Chemotherapy, Carcinoma, Transitional Cell, Bladder cancer, Proportional hazards model, business.industry, Hazard ratio, Immunotherapy, Middle Aged, medicine.disease, Confidence interval, Treatment Outcome, 030220 oncology & carcinogenesis, Urothelial carcinoma, Female, business, hormones, hormone substitutes, and hormone antagonists, Progressive disease

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e43a0ba091aad15d616915b92eba24e2
https://pubmed.ncbi.nlm.nih.gov/33153815

المؤلفون: Motzer RJ; Memorial Sloan Kettering Cancer Center, New York, NY., Porta C; University of Bari 'A. Moro,' Bari, Italy.; University of Pavia, Pavia, Italy., Eto M; Kyushu University, Fukuoka, Japan., Powles T; The Royal Free NHS Trust, London, United Kingdom., Grünwald V; University Hospital Essen, Essen, Germany., Hutson TE; Texas Oncology, Dallas, TX., Alekseev B; P.A. Herzen Moscow Oncological Research Institute, Moscow, Russia., Rha SY; Yonsei Cancer Center, Yonsei University Health System, Seoul, South Korea., Merchan J; University of Miami Sylvester Comprehensive Cancer Center, Miami, FL., Goh JC; ICON Research, South Brisbane & Queensland University of Technology, Brisbane, Queensland, Australia., Lalani AA; Juravinski Cancer Centre, McMaster University, Hamilton, Ontario, Canada., De Giorgi U; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Italy., Melichar B; Palacky University, and University Hospital Olomouc, Olomouc, Czech Republic., Hong SH; Seoul St Mary's Hospital, The Catholic University of Korea, Seoul, South Korea., Gurney H; Macquarie University, Sydney, NSW, Australia., Méndez-Vidal MJ; Maimonides Institute for Biomedical research of Cordoba (IMIBIC) Hospital Universitario Reina Sofía, Medical Oncology Department, Córdoba, Spain., Kopyltsov E; State Institution of Healthcare 'Regional Clinical Oncology Dispensary,' Omsk, Russia., Tjulandin S; N N Blokhin National Medical Research Center for Oncology, Ministry of Health of the Russian Federation, Moscow, Russia., Gordoa TA; Hospital Universitario Ramón y Cajal, Madrid, Spain., Kozlov V; State budgetary Health Care Institution 'Novosibirsk Regional Clinical Oncology Dispensary,' Novosibirsk, Russia., Alyasova A; Prevoljskiy Region Medical Centre, Novgorod, Russia., Winquist E; Western University, London, Ontario, Canada., Maroto P; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Kim M; Seoul National University Hospital, Seoul, South Korea., Peer A; Rambam Health Care Campus, Haifa, Israel., Procopio G; Fondazione IRCCS Istituto Nazionale Tumori Milano, Milan, Italy., Takagi T; Tokyo Women's Medical University, Tokyo, Japan., Wong S; Western Health, Melbourne, Victoria, Australia., Bedke J; Department of Urology and Transplantation Surgery, Klinikum Stuttgart, Stuttgart, Germany., Schmidinger M; Department of Urology, Medical University of Vienna, Vienna, Austria., Rodriguez-Lopez K; Merck & Co, Inc, Rahway, NJ., Burgents J; Merck & Co, Inc, Kenilworth, NJ., He C; Eisai Inc, Nutley, NJ., Okpara CE; Eisai Ltd, Hatfield, UK., McKenzie J; Eisai Inc, Nutley, NJ., Choueiri TK; Dana-Farber Cancer Institute, Boston, MA.

مؤلفون مشاركون: CLEAR Trial Investigators

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Apr 10; Vol. 42 (11), pp. 1222-1228. Date of Electronic Publication: 2024 Jan 16.

نوع المنشور: Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Renal Cell*/pathology , Kidney Neoplasms*/pathology , Phenylurea Compounds* , Quinolines* , Antibodies, Monoclonal, Humanized*, Humans ; Sunitinib/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Survival Analysis

المؤلفون: Rha SY; Department of Medical Oncology, Yonsei Cancer Center, Yonsei University Health System, Seoul, South Korea., Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Matveev VB; Department of Urology, Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology' of the Ministry of Health of the Russian Federation, Moscow, Russia., Alyasova A; Department of Oncology, Prevoljskiy Region Medical Centre, Novgorod, Russia., Hong SH; Department of Urology, Seoul St. Mary's Hospital, Seoul, South Korea., Gordoa TA; Department of Medical Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain., Gurney H; Department of Medical Oncology, Macquarie University, Sydney, New South Wales, Australia., Bjarnason GA; Division of Medical Oncology, Department of Medicine, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Buchler T; Department of Oncology, First Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic., Pedrazzoli P; Department of Internal Medicine and Medical Therapy, University of Pavia and Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Takagi T; Department of Urology, Tokyo Women's Medical University Hospital, Tokyo, Japan., Park SH; Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea., Lee JL; Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea., Perini RF; Clinical Research, Merck & Co., Inc., Rahway, New Jersey, USA., He CS; Biostatistics, Oncology Business Group, Eisai Inc., Nutley, New Jersey, USA., McKenzie JA; Clinical Research, Oncology Business Group, Eisai Inc., Nutley, New Jersey, USA., Eto M; Department of Urology, Kyushu University, Fukuoka, Japan.

المصدر: International journal of cancer [Int J Cancer] 2023 Sep 15; Vol. 153 (6), pp. 1241-1250. Date of Electronic Publication: 2023 Jun 09.

نوع المنشور: Equivalence Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Renal Cell*/drug therapy , Carcinoma, Renal Cell*/ethnology , Carcinoma, Renal Cell*/pathology , Kidney Neoplasms*/drug therapy , Kidney Neoplasms*/ethnology , Kidney Neoplasms*/pathology, Humans ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; East Asian People ; Sunitinib/therapeutic use

المؤلفون: Castillón JC; Servicio de Oncología Médica, Hospital Universitario Vall D'Hebron, Ps Vall d'Hebron, 119-129, 08035, Barcelona, Spain. jacapdevila@vhebron.net., Gordoa TA; Servicio de Oncología Médica, Hospital Universitario Ramón y Cajal, Madrid, Spain., Bayonas AC; Servicio de Oncología Médica, Hospital Universitario Morales Meseguer, Murcia, Spain., Carretero AC; Servicio de Oncología Médica, Hospital Universitario La Paz, Madrid, Spain., García-Carbonero R; Servicio de Oncología Médica, Hospital Universitario 12 de Octubre, Madrid, Spain., Pulido EG; Servicio de Oncología Médica, MD Anderson Cancer Center, Madrid, Spain., Fonseca PJ; Servicio de Oncología Médica, Hospital Universitario Central de Asturias, Oviedo, Spain., Lete AL; Servicio de Oncología Médica, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Huerta AS; Servicio de Oncología Médica, Hospital Universitari I Politècnic la Fe, Valencia, Spain., Plazas JG; Servicio de Oncología Médica, Hospital General Universitario de Elche, Alicante, Spain.

المصدر: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2023 Sep; Vol. 25 (9), pp. 2692-2706. Date of Electronic Publication: 2023 May 19.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Bronchial Neoplasms*/diagnosis , Bronchial Neoplasms*/therapy , Carcinoma, Neuroendocrine* , Neuroendocrine Tumors*/diagnosis , Neuroendocrine Tumors*/therapy, Humans ; Algorithms

المؤلفون: Gómez-Vecino A; Instituto de Biología Molecular y Celular del Cáncer (IBMCC-CIC), Universidad de Salamanca/CSIC, Salamanca, 37007, Spain.; Instituto de Investigación Biosanitaria de Salamanca (IBSAL), Salamanca, 37007, Spain., Corchado-Cobos R; Instituto de Biología Molecular y Celular del Cáncer (IBMCC-CIC), Universidad de Salamanca/CSIC, Salamanca, 37007, Spain.; Instituto de Investigación Biosanitaria de Salamanca (IBSAL), Salamanca, 37007, Spain., Blanco-Gómez A; Instituto de Biología Molecular y Celular del Cáncer (IBMCC-CIC), Universidad de Salamanca/CSIC, Salamanca, 37007, Spain.; Instituto de Investigación Biosanitaria de Salamanca (IBSAL), Salamanca, 37007, Spain., García-Sancha N; Instituto de Biología Molecular y Celular del Cáncer (IBMCC-CIC), Universidad de Salamanca/CSIC, Salamanca, 37007, Spain.; Instituto de Investigación Biosanitaria de Salamanca (IBSAL), Salamanca, 37007, Spain., Castillo-Lluva S; Departamento de Bioquímica y Biología Molecular, Facultad de Ciencias Químicas, Universidad Complutense, Madrid, 28040, Spain.; Instituto de Investigaciones Sanitarias San Carlos (IdISSC), Madrid, Spain., Martín-García A; Instituto de Investigación Biosanitaria de Salamanca (IBSAL), Salamanca, 37007, Spain.; Servicio de Cardiología, Hospital Universitario de Salamanca, Universidad de Salamanca, and CIBER.CV, Salamanca, 37007, Spain., Mendiburu-Eliçabe M; Instituto de Biología Molecular y Celular del Cáncer (IBMCC-CIC), Universidad de Salamanca/CSIC, Salamanca, 37007, Spain.; Instituto de Investigación Biosanitaria de Salamanca (IBSAL), Salamanca, 37007, Spain., Prieto C; Servicio de Bioinformática, Nucleus, Universidad de Salamanca, Salamanca, 37007, Spain., Ruiz-Pinto S; Human Genotyping Unit-CeGen, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), 28029, Spain., Pita G; Human Genotyping Unit-CeGen, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), 28029, Spain., Velasco-Ruiz A; Human Genotyping Unit-CeGen, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), 28029, Spain., Patino-Alonso C; Instituto de Investigación Biosanitaria de Salamanca (IBSAL), Salamanca, 37007, Spain.; Departamento de Estadística, Universidad de Salamanca, Salamanca, 37007, Spain; and Centro de Investigación Institucional (CII). Universidad Bernardo O'Higgins, 1497. Santiago, Chile., Galindo-Villardón P; Instituto de Investigación Biosanitaria de Salamanca (IBSAL), Salamanca, 37007, Spain.; Departamento de Estadística, Universidad de Salamanca, Salamanca, 37007, Spain; and Centro de Investigación Institucional (CII). Universidad Bernardo O'Higgins, 1497. Santiago, Chile., Vera-Pedrosa ML; Centro Nacional de Investigaciones Cardiovasculares (CNIC) Carlos III, Madrid, 28029, Spain., Jalife J; Centro Nacional de Investigaciones Cardiovasculares (CNIC) Carlos III, Madrid, 28029, Spain., Mao JH; Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.; Berkeley Biomedical Data Science Center, Lawrence Berkeley National Laboratory, Berkeley, CA, USA., de Plasencia GM; Instituto de Investigación Biosanitaria de Salamanca (IBSAL), Salamanca, 37007, Spain.; Servicio de Cardiología, Hospital Universitario de Salamanca, Universidad de Salamanca, and CIBER.CV, Salamanca, 37007, Spain., Castellanos-Martín A; Instituto de Biología Molecular y Celular del Cáncer (IBMCC-CIC), Universidad de Salamanca/CSIC, Salamanca, 37007, Spain.; Instituto de Investigación Biosanitaria de Salamanca (IBSAL), Salamanca, 37007, Spain., Freire MDMS; Instituto de Biología Molecular y Celular del Cáncer (IBMCC-CIC), Universidad de Salamanca/CSIC, Salamanca, 37007, Spain.; Instituto de Investigación Biosanitaria de Salamanca (IBSAL), Salamanca, 37007, Spain., Fraile-Martín S; Servicio de Patología Molecular Comparada, Instituto de Biología Molecular y Celular del Cáncer (IBMCC-CIC), Universidad de Salamanca, Salamanca, 37007, Spain., Rodrigues-Teixeira T; Servicio de Patología Molecular Comparada, Instituto de Biología Molecular y Celular del Cáncer (IBMCC-CIC), Universidad de Salamanca, Salamanca, 37007, Spain., García-Macías C; Servicio de Patología Molecular Comparada, Instituto de Biología Molecular y Celular del Cáncer (IBMCC-CIC), Universidad de Salamanca, Salamanca, 37007, Spain., Galvis-Jiménez JM; Instituto de Biología Molecular y Celular del Cáncer (IBMCC-CIC), Universidad de Salamanca/CSIC, Salamanca, 37007, Spain.; Instituto de Investigación Biosanitaria de Salamanca (IBSAL), Salamanca, 37007, Spain.; Instituto Nacional de Cancerología de Colombia, Bogotá D. C., Colombia., García-Sánchez A; Instituto de Investigación Biosanitaria de Salamanca (IBSAL), Salamanca, 37007, Spain.; Servicio de Bioquímica Clínica, Hospital Universitario de Salamanca, Salamanca, 37007, Spain., Isidoro-García M; Instituto de Investigación Biosanitaria de Salamanca (IBSAL), Salamanca, 37007, Spain.; Servicio de Bioquímica Clínica, Hospital Universitario de Salamanca, Salamanca, 37007, Spain.; Departamento de Medicina, Universidad de Salamanca, Salamanca, 37007, Spain., Fuentes M; Instituto de Biología Molecular y Celular del Cáncer (IBMCC-CIC), Universidad de Salamanca/CSIC, Salamanca, 37007, Spain.; Instituto de Investigación Biosanitaria de Salamanca (IBSAL), Salamanca, 37007, Spain.; Departamento de Medicina, Universidad de Salamanca, Salamanca, 37007, Spain.; Unidad de Proteómica y Servicio General de Citometría de Flujo, Nucleus, Universidad de Salamanca, 37007, Spain., García-Cenador MB; Instituto de Investigación Biosanitaria de Salamanca (IBSAL), Salamanca, 37007, Spain.; Departamento de Cirugía, Universidad de Salamanca. Salamanca, 37007, Spain., García-Criado FJ; Instituto de Investigación Biosanitaria de Salamanca (IBSAL), Salamanca, 37007, Spain.; Departamento de Cirugía, Universidad de Salamanca. Salamanca, 37007, Spain., García JL; Instituto de Biología Molecular y Celular del Cáncer (IBMCC-CIC), Universidad de Salamanca/CSIC, Salamanca, 37007, Spain.; Instituto de Investigación Biosanitaria de Salamanca (IBSAL), Salamanca, 37007, Spain., Hernández-García MÁ; Servicio de Hematología, Hospital Universitario de Salamanca, CIBERONC, Salamanca, 37007, Spain., Hernández JJC; Instituto de Biología Molecular y Celular del Cáncer (IBMCC-CIC), Universidad de Salamanca/CSIC, Salamanca, 37007, Spain.; Instituto de Investigación Biosanitaria de Salamanca (IBSAL), Salamanca, 37007, Spain.; Departamento de Medicina, Universidad de Salamanca, Salamanca, 37007, Spain.; Servicio de Oncología, Hospital Universitario de Salamanca, Salamanca, 37007, Spain., Rodríguez-Sánchez CA; Instituto de Biología Molecular y Celular del Cáncer (IBMCC-CIC), Universidad de Salamanca/CSIC, Salamanca, 37007, Spain.; Instituto de Investigación Biosanitaria de Salamanca (IBSAL), Salamanca, 37007, Spain.; Departamento de Medicina, Universidad de Salamanca, Salamanca, 37007, Spain.; Servicio de Oncología, Hospital Universitario de Salamanca, Salamanca, 37007, Spain., Martín-Ruiz A; Instituto de Biología Molecular y Celular del Cáncer (IBMCC-CIC), Universidad de Salamanca/CSIC, Salamanca, 37007, Spain.; Instituto de Investigación Biosanitaria de Salamanca (IBSAL), Salamanca, 37007, Spain.; Servicio de Hematología, Hospital Universitario de Salamanca, CIBERONC, Salamanca, 37007, Spain., Pérez-López E; Instituto de Biología Molecular y Celular del Cáncer (IBMCC-CIC), Universidad de Salamanca/CSIC, Salamanca, 37007, Spain.; Instituto de Investigación Biosanitaria de Salamanca (IBSAL), Salamanca, 37007, Spain.; Servicio de Hematología, Hospital Universitario de Salamanca, CIBERONC, Salamanca, 37007, Spain., Pérez-Martínez A; Department of Paediatric Hemato-Oncology, Hospital Universitario La Paz, Madrid, 28046, Spain., Gutiérrez-Larraya F; Department of Paediatric Cardiology, Hospital Universitario La Paz, Madrid, 28046, Spain., Cartón AJ; Department of Paediatric Hemato-Oncology, Hospital Universitario La Paz, Madrid, 28046, Spain., García-Sáenz JÁ; Medical Oncology Service, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Hospital Clínico San Carlos, Madrid, 28040, Spain., Patiño-García A; Department of Pediatrics, University Clinic of Navarra, Solid Tumor Program, CIMA, Universidad de Navarra, IdisNA, Pamplona, 31008, Spain., Martín M; Gregorio Marañón Health Research Institute (IISGM), CIBERONC, Department of Medicine, Universidad Complutense, Madrid, 28007, Spain., Gordoa TA; Department of Medical Oncology, Hospital Universitario Ramón y Cajal, Madrid, 28034, Spain., Vulsteke C; Department of Molecular Imaging, Pathology, Radiotherapy and Oncology (MIPRO), Center for Oncological Research (CORE), Antwerp University, Antwerp, Belgium.; Department of Oncology, Integrated Cancer Center in Ghent, AZ Maria Middelares, Ghent, Belgium., Croes L; Department of Molecular Imaging, Pathology, Radiotherapy and Oncology (MIPRO), Center for Oncological Research (CORE), Antwerp University, Antwerp, Belgium.; Department of Oncology, Integrated Cancer Center in Ghent, AZ Maria Middelares, Ghent, Belgium., Hatse S; Laboratory of Experimental Oncology (LEO), Department of Oncology, KU Leuven, and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium., Brussel TV; VIB Center for Cancer Biology, VIB, Leuven, Belgium.; Laboratory of Translational Genetics, Department of Human Genetics, KU Leuven, 3000 Leuven, Belgium., Lambrechts D; VIB Center for Cancer Biology, VIB, Leuven, Belgium.; Laboratory of Translational Genetics, Department of Human Genetics, KU Leuven, 3000 Leuven, Belgium., Wildiers H; Department of General Medical Oncology and Multidisciplinary Breast Centre, University Hospitals Leuven, Leuven Cancer Institute, and Laboratory of Experimental Oncology (LEO), Department of Oncology, KU Leuven, Leuven, Belgium., Hang C; Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.; Berkeley Biomedical Data Science Center, Lawrence Berkeley National Laboratory, Berkeley, CA, USA., Holgado-Madruga M; Instituto de Investigación Biosanitaria de Salamanca (IBSAL), Salamanca, 37007, Spain.; Departamento de Fisiología y Farmacología, Universidad de Salamanca, 37007, Salamanca. Spain.; Instituto de Neurociencias de Castilla y León (INCyL), Salamanca, 37007, Spain., González-Neira A; Human Genotyping Unit-CeGen, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), 28029, Spain., Sánchez PL; Instituto de Investigación Biosanitaria de Salamanca (IBSAL), Salamanca, 37007, Spain.; Servicio de Cardiología, Hospital Universitario de Salamanca, Universidad de Salamanca, and CIBER.CV, Salamanca, 37007, Spain.; Departamento de Medicina, Universidad de Salamanca, Salamanca, 37007, Spain., Losada JP; Instituto de Biología Molecular y Celular del Cáncer (IBMCC-CIC), Universidad de Salamanca/CSIC, Salamanca, 37007, Spain.; Instituto de Investigación Biosanitaria de Salamanca (IBSAL), Salamanca, 37007, Spain.

المصدر: BioRxiv : the preprint server for biology [bioRxiv] 2023 Jan 06. Date of Electronic Publication: 2023 Jan 06.

نوع المنشور: Preprint

بيانات الدورية: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

المؤلفون: Dawod M; Department of Medical Oncology, ENETs, Centre of Excellence, The Christie NHS Foundation Trust, Manchester, UK., Gordoa TA; Department of Medical Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain., Cives M; Department of Medical Oncology, University of Bari, Bari, Italy., De Mestier L; Department of Gastroenterology, Beaujon Hospital, Université de Paris, Clichy, France., Crona J; Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden., Spada F; Gastrointestinal Medical Oncology and Neuroendocrine Tumors Unit, European Institute of Oncology, Milan, Italy., Oberg K; Department of Endocrinology, Universitatsklinikum Erlangen, Erlangen, Germany., Pavel M; Department of Medical Oncology, ENETs, Centre of Excellence, The Christie NHS Foundation Trust, Division of Cancer Sciences, University of Manchester, Manchester, UK., Lamarca A; The Christie NHS Foundation Trust, Wilmslow Road, M20 4BX, Manchester, UK. angela.lamarca@nhs.net.

المصدر: Current treatment options in oncology [Curr Treat Options Oncol] 2021 Jun 29; Vol. 22 (8), pp. 73. Date of Electronic Publication: 2021 Jun 29.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Current Science, Inc Country of Publication: United States NLM ID: 100900946 Publication Model: Electronic Cited Medium: Internet ISSN: 1534-6277 (Electronic) Linking ISSN: 15346277 NLM ISO Abbreviation: Curr Treat Options Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Intestinal Neoplasms/*drug therapy , Neuroendocrine Tumors/*drug therapy, Clinical Trials as Topic ; Everolimus/therapeutic use ; Humans ; Intestine, Small ; Palliative Care ; Practice Guidelines as Topic ; Somatostatin/therapeutic use